Autophagy as a basis for the health-promoting effects of vitamin D

Trends in Molecular Medicine

Volumn 16, Issue 7, 2010, Pages 295-302

  Høyer Hansen, Maria ^a   Nordbrandt, Sasja Pauline Schultz ^a   Jäättelä, Marja ^a  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

VITAMIN D;

ARTICLE; AUTOPHAGY;

ANIMALS; AUTOPHAGY; HEALTH; HUMANS; MACROPHAGES; MYCOBACTERIUM TUBERCULOSIS; NEOPLASMS; TUBERCULOSIS; VITAMIN D;

MYCOBACTERIUM TUBERCULOSIS;

EID: 77954386688     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2010.04.005     Document Type: Article

References (77)

1. Jones G. Expanding role for vitamin D in chronic kidney disease: importance of blood 25-OH-D levels and extra-renal 1alpha-hydroxylase in the classical and nonclassical actions of 1alpha,25-dihydroxyvitamin D(3). Semin Dial 2007, 20:316-324.
2. Norman A.W. From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am. J. Clin. Nutr. 2008, 88:491S-499S.
3. White J.H. Vitamin D signaling, infectious diseases, and regulation of innate immunity. Infect. Immun. 2008, 76:3837-3843.
4. Zittermann A., et al. Circulating calcitriol concentrations and total mortality. Clin. Chem. 2009, 55:1163-1170.
5. Bikle D.D. Vitamin D: newly discovered actions require reconsideration of physiologic requirements. Trends Endocrinol. Metab. 2010, doi:10.1016/j.tem.2010.01.003.
6. Zittermann A. Vitamin D in preventive medicine: are we ignoring the evidence?. Br. J. Nutr. 2003, 89:552-572.
7. Hoyer-Hansen M., et al. Control of macroautophagy by calcium, calmodulin-dependent kinase kinase-beta, and Bcl-2. Mol. Cell 2007, 25:193-205.
8. Hoyer-Hansen M., et al. Vitamin D analog EB1089 triggers dramatic lysosomal changes and Beclin 1-mediated autophagic cell death. Cell Death Differ. 2005, 12:1297-1309.
9. Tavera-Mendoza L., et al. Convergence of vitamin D and retinoic acid signalling at a common hormone response element. EMBO Rep. 2006, 7:180-185.
10. Demasters G., et al. Potentiation of radiation sensitivity in breast tumor cells by the vitamin D3 analogue, EB 1089, through promotion of autophagy and interference with proliferative recovery. Mol. Cancer Ther. 2006, 5:2786-2797.
11. Wang J., et al. Vitamin D3 induces autophagy of human myeloid leukemia cells. J. Biol. Chem. 2008, 283:25596-25605.
12. Yuk J.M., et al. Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. Cell Host Microbe 2009, 6:231-243.
13. Kamen D.L., Tangpricha V. Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity. J. Mol. Med. 2010, 88:441-450.
14. Hewison M., et al. Extra-renal 25-hydroxyvitamin D3-1alpha-hydroxylase in human health and disease. J. Steroid. Biochem. Mol. Biol. 2007, 103:316-321.
15. Levine B., Kroemer G. Autophagy in the pathogenesis of disease. Cell 2008, 132:27-42.
16. Mizushima N., et al. Autophagy fights disease through cellular self-digestion. Nature 2008, 451:1069-1075.
17. Lum J.J., et al. Autophagy in metazoans: cell survival in the land of plenty. Nat. Rev. Mol. Cell Biol. 2005, 6:439-448.
18. Boya P., et al. Inhibition of macroautophagy triggers apoptosis. Mol. Cell Biol. 2005, 25:1025-1040.
19. De Meyer G.R., Martinet W. Autophagy in the cardiovascular system. Biochim. Biophys. Acta 2009, 1793:1485-1495.
20. Halapas A., et al. Autophagy: a target for therapeutic interventions in myocardial pathophysiology. Expert. Opin. Ther. Targets 2008, 12:1509-1522.
21. Goldman S., et al. Autophagy and adipogenesis: implications in obesity and type II diabetes. Autophagy 2010, 6:179-181.
22. Kroemer G., Jäättelä M. Lysosomes and autophagy in cell death control. Nat. Rev. Cancer 2005, 5:886-897.
23. Hoyer-Hansen M., Jaattela M. Autophagy: an emerging target for cancer therapy. Autophagy 2008, 4:574-580.
24. Mathiasen I.S., et al. EB1089, a novel vitamin D analogue, has strong antiproliferative and differentation inducing effects on cancer cells. J. Steroid. Biochem. Mol. Biol. 1993, 46:365-371.
25. Mathiasen I.S., et al. Apoptosis induced by vitamin D compounds in breast cancer cells is inhibited by Bcl-2 but does not involve known caspases or p53. Cancer Res. 1999, 59:4848-4856.
26. Mathiasen I.S., et al. Calcium and calpain as key mediators of apoptosis-like death induced by vitamin D compounds in breast cancer cells. J. Biol. Chem. 2002, 277:30738-30745.
27. Mathiasen I.S., et al. Sensitization to TNF-induced apoptosis by 1,25-dihydroxy vitamin D(3) involves up-regulation of the TNF receptor 1 and cathepsin B. Int. J. Cancer 2001, 93:224-231.
28. Hoyer-Hansen M., Jaattela M. Connecting endoplasmic reticulum stress to autophagy by unfolded protein response and calcium. Cell Death Differ. 2007, 14:1576-1582.
29. Hawley S.A., et al. Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab. 2005, 2:9-19.
30. Woods A., et al. Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab. 2005, 2:21-33.
31. Herrero-Martin G., et al. TAK1 activates AMPK-dependent cytoprotective autophagy in TRAIL-treated epithelial cells. EMBO J. 2009, 28:677-685.
32. Liang J., et al. The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis. Nat. Cell Biol. 2007, 9:218-224.
33. Hoyer-Hansen M., Jaattela M. AMP-activated protein kinase: a universal regulator of autophagy?. Autophagy 2007, 3:381-383.
34. Corcelle E.A., et al. Apoptosis and autophagy: Targeting autophagy signalling in cancer cells - 'trick or treats'?. Febs. J. 2009, 276:6084-6096.
35. Xie Z., Klionsky D.J. Autophagosome formation: core machinery and adaptations. Nat. Cell Biol. 2007, 9:1102-1109.
36. Tomasinsig L., et al. The human cathelicidin LL-37 modulates the activities of the P2X7 receptor in a structure-dependent manner. J. Biol. Chem. 2008, 283:30471-30481.
37. Correa, G. et al. (2010) Activation of the P2X(7) receptor triggers the elimination of Toxoplasma gondii tachyzoites from infected macrophages. Microbes Infect. doi:10.1016/j.micinf.2010.03.004.
38. Kriebitzsch C., et al. The impact of 1,25(OH)2D3 and its structural analogs on gene expression in cancer cells--a microarray approach. Anticancer Res. 2009, 29:3471-3483.
39. Kricker A., Armstrong B. Does sunlight have a beneficial influence on certain cancers?. Prog. Biophys Mol. Biol. 2006, 92:132-139.
40. Mullin G.E., Dobs A. Vitamin d and its role in cancer and immunity: a prescription for sunlight. Nutr. Clin. Pract. 2007, 22:305-322.
41. Tavera-Mendoza, L.E. and White, J.H. (2007) Cell defenses and the sunshine vitamin. Sci. Am. 297, 62-65, 68-70, 72.
42. Ordonez-Moran P., et al. Vitamin D and cancer: an update of in vitro and in vivo data. Front Biosci. 2005, 10:2723-2749.
43. Reichrath J., et al. Vitamin D analogs in cancer prevention and therapy: an ancient friend revisited. Anticancer Res. 2009, 29:3469-3470.
44. Welsh J. Vitamin D and breast cancer: insights from animal models. Am. J. Clin. Nutr. 2004, 80:1721S-1724S.
45. Liang X.H., et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 1999, 402:672-676.
46. Qu X., et al. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J. Clin. Invest. 2003, 112:1809-1820.
47. Jin S., White E. Tumor suppression by autophagy through the management of metabolic stress. Autophagy 2008, 4:563-566.
48. Welsh J. Induction of apoptosis in breast cancer cells in response to vitamin D and antiestrogens. Biochem. Cell Biol. 1994, 72:537-545.
49. Vandewalle B., et al. Vitamin-D3 derivatives and breast-tumor cell growth: effect on intracellular calcium and apoptosis. Int. J. Cancer 1995, 61:806-811.
50. Narvaez C.J., Welsh J. Role of mitochondria and caspases in vitamin D-mediated apoptosis of MCF-7 breast cancer cells. J. Biol. Chem. 2001, 276:9101-9107.
51. Buzzai M., et al. Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth. Cancer Res. 2007, 67:6745-6752.
52. Wright J.L., Stanford J.L. Metformin use and prostate cancer in Caucasian men: results from a population-based case-control study. Cancer Causes Control 2009, 20:1617-1622.
53. Jäättelä M. Multiple cell death pathways as regulators of tumour initiation and progression. Oncogene 2004, 23:2746-2756.
54. Groth-Pedersen L., et al. Vincristine induces dramatic lysosomal changes and sensitizes cancer cells to lysosome destabilizing siramesine. Cancer Res. 2007, 67:2217-2225.
55. Fehrenbacher N., et al. Sensitization to the lysosomal cell death pathway by oncogene-induced down-regulation of lysosome-associated membrane proteins 1 and 2. Cancer Res. 2008, 68:6623-6633.
56. Fehrenbacher N., et al. Sensitization to the lysosomal cell death pathway upon immortalization and transformation. Cancer Res. 2004, 64:5301-5310.
57. Rook G.A., et al. Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. Immunology 1986, 57:159-163.
58. Liu P.T., et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006, 311:1770-1773.
59. Reichel H., et al. 25-Hydroxyvitamin D3 metabolism by lipopolysaccharide-stimulated normal human macrophages. J. Clin. Endocrinol. Metab. 1987, 64:1-9.
60. Vergne I., et al. Cell biology of mycobacterium tuberculosis phagosome. Annu. Rev. Cell Dev. Biol. 2004, 20:367-394.
61. Gutierrez M.G., et al. Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell 2004, 119:753-766.
62. Singh S.B., et al. Human IRGM induces autophagy to eliminate intracellular mycobacteria. Science 2006, 313:1438-1441.
63. Xu Y., et al. Toll-like receptor 4 is a sensor for autophagy associated with innate immunity. Immunity 2007, 27:135-144.
64. Giovannucci E. Vitamin D and cardiovascular disease. Curr. Atheroscler Rep. 2009, 11:456-461.
65. Kendrick J., et al. 25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey. Atherosclerosis 2009, 205:255-260.
66. Adams J.S., Hewison M. Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat. Clin. Pract. Endocrinol. Metab. 2008, 4:80-90.
67. Alvarez J.A., Ashraf A. Role of vitamin d in insulin secretion and insulin sensitivity for glucose homeostasis. Int. J. Endocrinol. 2010, 2010:351385.
68. Tanghetti E.A. The role of topical vitamin D modulators in psoriasis therapy. J. Drugs Dermatol. 2009, 8:s4-8.
69. Bikle D.D. Vitamin D and the skin. J. Bone Miner Metab. 2010, 28:117-130.
70. Colston K.W., Hansen C.M. Mechanisms implicated in the growth regulatory effects of vitamin D in breast cancer. Endocr. Relat. Cancer 2002, 9:45-59.
71. Nakagawa K., et al. 1 alpha,25-Dihydroxyvitamin D(3) is a preventive factor in the metastasis of lung cancer. Carcinogenesis 2005, 26:429-440.
72. Chung I., et al. Role of vitamin D receptor in the antiproliferative effects of calcitriol in tumor-derived endothelial cells and tumor angiogenesis in vivo. Cancer Res. 2009, 69:967-975.
73. Garland C.F., et al. Vitamin D for cancer prevention: global perspective. Ann. Epidemiol. 2009, 19:468-483.
74. Lapillonne A. Vitamin D deficiency during pregnancy may impair maternal and fetal outcomes. Med. Hypotheses 2010, 74:71-75.
75. Merewood A., et al. Association between vitamin D deficiency and primary cesarean section. J. Clin. Endocrinol. Metab. 2009, 94:940-945.
76. Tuohimaa P., et al. Vitamin D, nervous system and aging. Psychoneuroendocrinology 2009, 34(Suppl 1):S278-286.
77. Brown A.J. Therapeutic uses of vitamin D analogues. Am. J. Kidney Dis. 2001, 38:S3-S19.